Project Number ADDF-43 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2021 View Full Project Details for MIB-626 For Treatment of Mild Dementia Patients Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator Livingston, David Principal Investigator Livingston, David Awardee Organization Metro International Biotech Awardee State Massachusetts Contact PI Country United States Project Detail FY Overall Cost $3,000,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
